Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

The Author's Response: Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer.

Paik WH, Kim YT.

J Korean Med Sci. 2016 Sep;31(9):1505-6. doi: 10.3346/jkms.2016.31.9.1505. No abstract available.

2.

Efficacy of Neo-Adjuvant Chemoradiotherapy for Resectable Pancreatic Adenocarcinoma: A PRISMA-Compliant Meta-Analysis and Systematic Review.

Liu W, Fu XL, Yang JY, Liu DJ, Li J, Zhang JF, Huo YM, Yang MW, Hua R, Sun YW.

Medicine (Baltimore). 2016 Apr;95(15):e3009. doi: 10.1097/MD.0000000000003009.

3.

Meta-analyses of treatment standards for pancreatic cancer.

Gong J, Tuli R, Shinde A, Hendifar AE.

Mol Clin Oncol. 2016 Mar;4(3):315-325. Epub 2015 Dec 18.

4.

Local Ablative Strategies for Ductal Pancreatic Cancer (Radiofrequency Ablation, Irreversible Electroporation): A Review.

Paiella S, Salvia R, Ramera M, Girelli R, Frigerio I, Giardino A, Allegrini V, Bassi C.

Gastroenterol Res Pract. 2016;2016:4508376. doi: 10.1155/2016/4508376. Epub 2016 Feb 15. Review.

5.

Neoadjuvant radiotherapeutic strategies in pancreatic cancer.

Roeder F.

World J Gastrointest Oncol. 2016 Feb 15;8(2):186-97. doi: 10.4251/wjgo.v8.i2.186. Review.

6.

Robotic radiosurgery in pancreatic cancer: A systematic review.

Buwenge M, Cellini F, Silvestris N, Cilla S, Deodato F, Macchia G, Mattiucci GC, Valentini V, Morganti AG.

World J Gastroenterol. 2015 Aug 21;21(31):9420-9. doi: 10.3748/wjg.v21.i31.9420.

7.

Pancreas club international joint symposium on pancreatic cancer 2012, Kyoto: down staging chemo┬▒radiotherapy for borderline resectable pancreatic cancer.

Kang CM, Hwang HK, Lee WJ.

Korean J Hepatobiliary Pancreat Surg. 2013 Feb;17(1):8-13. doi: 10.14701/kjhbps.2013.17.1.8. Epub 2013 Feb 28.

8.

Objective Assessment of Surgical Restaging after Concurrent Chemoradiation for Locally Advanced Pancreatic Cancer.

Paik WH, Lee SH, Kim YT, Park JM, Song BJ, Ryu JK.

J Korean Med Sci. 2015 Jul;30(7):917-23. doi: 10.3346/jkms.2015.30.7.917. Epub 2015 Jun 10.

9.

New challenges in perioperative management of pancreatic cancer.

Puleo F, Mar├ęchal R, Demetter P, Bali MA, Calomme A, Closset J, Bachet JB, Deviere J, Van Laethem JL.

World J Gastroenterol. 2015 Feb 28;21(8):2281-93. doi: 10.3748/wjg.v21.i8.2281. Review.

10.

Inter-observer variability of clinical target volume delineation in radiotherapy treatment of pancreatic cancer: a multi-institutional contouring experience.

Caravatta L, Macchia G, Mattiucci GC, Sainato A, Cernusco NL, Mantello G, Di Tommaso M, Trignani M, De Paoli A, Boz G, Friso ML, Fusco V, Di Nicola M, Morganti AG, Genovesi D.

Radiat Oncol. 2014 Sep 8;9:198. doi: 10.1186/1748-717X-9-198.

11.

Neoadjuvant strategies for pancreatic cancer.

Polistina F, Di Natale G, Bonciarelli G, Ambrosino G, Frego M.

World J Gastroenterol. 2014 Jul 28;20(28):9374-83. doi: 10.3748/wjg.v20.i28.9374. Review.

12.

Cavitation-enhanced MR-guided focused ultrasound ablation of rabbit tumors in vivo using phase shift nanoemulsions.

Kopechek JA, Park EJ, Zhang YZ, Vykhodtseva NI, McDannold NJ, Porter TM.

Phys Med Biol. 2014 Jul 7;59(13):3465-81. doi: 10.1088/0031-9155/59/13/3465. Epub 2014 Jun 5.

13.

Phase II Trial of Cetuximab and Conformal Radiotherapy Only in Locally Advanced Pancreatic Cancer with Concurrent Tissue Sampling Feasibility Study.

Rembielak AI, Jain P, Jackson AS, Green MM, Santorelli GR, Whitfield GA, Crellin A, Garcia-Alonso A, Radhakrishna G, Cullen J, Taylor MB, Swindell R, West CM, Valle J, Saleem A, Price PM.

Transl Oncol. 2014 Feb 1;7(1):55-64. eCollection 2014 Feb.

14.

Clinical predictors of resectability of pancreatic adenocarcinoma.

Almadi MA, Alharbi O, Azzam N, Altayeb M, Javed M, Alsaif F, Hassanain M, Alsharabi A, Al-Saleh K, Aljebreen AM.

Saudi J Gastroenterol. 2013 Nov-Dec;19(6):278-85. doi: 10.4103/1319-3767.121036.

15.

Gemcitabine plus Nab-Paclitaxel with chemoradiation in locally advanced pancreatic cancer (LAPC).

Olowokure O, Torregroza-Sanchez MP, Bedoya-Apraez ID.

J Gastrointest Oncol. 2013 Jun;4(2):E16-8. doi: 10.3978/j.issn.2078-6891.2013.013.

16.

FOLFIRINOX in locally advanced pancreatic cancer: the Massachusetts General Hospital Cancer Center experience.

Faris JE, Blaszkowsky LS, McDermott S, Guimaraes AR, Szymonifka J, Huynh MA, Ferrone CR, Wargo JA, Allen JN, Dias LE, Kwak EL, Lillemoe KD, Thayer SP, Murphy JE, Zhu AX, Sahani DV, Wo JY, Clark JW, Fernandez-del Castillo C, Ryan DP, Hong TS.

Oncologist. 2013;18(5):543-8. doi: 10.1634/theoncologist.2012-0435. Epub 2013 May 8.

17.

Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review.

Fegrachi S, Besselink MG, van Santvoort HC, van Hillegersberg R, Molenaar IQ.

HPB (Oxford). 2014 Feb;16(2):119-23. doi: 10.1111/hpb.12097. Epub 2013 Apr 18. Review.

18.

Pancreaticoduodenectomy following chemoradiotherapy for locally advanced adenocarcinoma of the pancreatic head.

Denost Q, Laurent C, Adam JP, Capdepont M, Vendrely V, Collet D, Cunha AS.

HPB (Oxford). 2013 Sep;15(9):716-23. doi: 10.1111/hpb.12039. Epub 2013 Jan 10.

19.

Retroperitoneal dissection in patients with borderline resectable pancreatic cancer: operative principles and techniques.

Katz MH, Lee JE, Pisters PW, Skoracki R, Tamm E, Fleming JB.

J Am Coll Surg. 2012 Aug;215(2):e11-8. doi: 10.1016/j.jamcollsurg.2012.05.015.

20.

Expanding surgical treatment of pancreatic cancer: the role of regional chemotherapy.

Davis JL, Pandalai PK, Ripley RT, Langan RC, Avital I.

Pancreas. 2012 Jul;41(5):678-84. doi: 10.1097/MPA.0b013e318249955a. Review.

Items per page

Supplemental Content

Write to the Help Desk